Review of the CHARM-Alternative trial

Cardiology Trials ›

10:03 | Jun 24th

THE LANCET 2003;362:772-776Background: Angiotensin converting enzyme inhibitors (ACEi) reduce mortality and morbidity in patients with systolic heart failure (see CONSENSUS and SOLVD trials). However,...Show More